Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.59 |
| ▸ | PPARA | Q07869 | 4/20 | 0.59 |
| ▸ | PPARD | Q03181 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.41 |
| ▸ | ULK1 | O75385 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3683528 | 0.76 | PPARG (0.64) | PPARGPPARAPPARDRAB9APOLB | |
| SCHEMBL20280514 | 0.75 | PPARG (1.00) | PPARGPPARAPPARD | |
| Gsk-9578 SCHEMBL30475595 | 0.75 | PPARG (1.00) | PPARGPPARAPPARD | |
| SCHEMBL15480431 | 0.73 | POLB (0.66) | RAB9APOLBNPC1HDAC3HDAC1 | |
| SCHEMBL4133118 | 0.70 | POLB (0.58) | RAB9APOLBHDAC3HDAC1TP53 | |
| SCHEMBL31203495 | 0.70 | HDAC3 (0.54) | RAB9APOLBHDAC3HDAC1NCOR2 | |
| SCHEMBL10115113 | 0.69 | HDAC3 (0.56) | RAB9APOLBHDAC3HDAC1NCOR2 | |
| SCHEMBL12436841 | 0.69 | PPARA (0.63) | PPARGPPARAPPARDPOLBALDH1A1 | |
| SCHEMBL15480422 | 0.69 | HDAC1 (0.63) | RAB9APOLBNPC1HDAC3HDAC1 | |
| SCHEMBL6274364 | 0.68 | POLB (0.58) | RAB9APOLBNPC1HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014015318-A1 | SOLUBLE COMPOUNDS FOR IMPROVED GENE THERAPY METHODS | BLUEBIRD BIO, INC. (US) | 2014-01-23 | — | — | WO | claimed |
| US-20100240627-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | UNIVERSITEIT GENT | 2010-09-23 | — | — | US | claimed |
| US-20090111782-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | GHENT UNIVERSITY (BE) | 2009-04-30 | — | — | US | claimed |
| EP-4203941-A1 | COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2023-07-05 | — | — | EP | disclosed |
| US-20230201226-A1 | COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-06-29 | — | — | US | disclosed |
| WO-2022044014-A1 | COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-03-03 | — | — | WO | disclosed |
| WO-2014015318-A1 | SOLUBLE COMPOUNDS FOR IMPROVED GENE THERAPY METHODS | BLUEBIRD BIO, INC. (US) | 2014-01-23 | — | — | WO | disclosed |
| US-20110300129-A1 | SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY | UNIVERSITY OF ROCHESTER (US) | 2011-12-08 | — | — | US | disclosed |
| US-20100240627-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | UNIVERSITEIT GENT | 2010-09-23 | — | — | US | disclosed |
| WO-2010075037-A1 | SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY | UNIVERSITY OF ROCHESTER (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20090111782-A1 | COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | GHENT UNIVERSITY (BE) | 2009-04-30 | — | — | US | disclosed |